Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. Stock: price and insider trades · China
百诚医药
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.: what insiders have been doing
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. is a Health Care company. Its directors and officers file their transactions with SSE / SZSE (CSRC). Between 5 November 2025 and 5 November 2026, 1 insider published 1 filing.
There is no open-market purchase to report; the filings show 1 sale worth €6,619 by 1 insider. At €6,619, the sale published on 1 December 2025 by 严洪兵 is the largest of the period.
Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning.
Across the 519 companies tracked on its exchange, the median is 2 filings; at 1 filing, this issuer sits below that mark. Since 2025, the database holds no purchases and 2 sales by insiders of the company.
Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and Vetoquinol SA. Source: insider filings from SSE / SZSE (CSRC). Past trades are no guide to future returns.
Who traded when
BuySaleThis score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
About Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.
百诚医药 is a company focused on the healthcare and pharmaceutical sector, providing products and services related to health care. It is listed on the XSHE market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
